BioCentury | Dec 21, 2020
Translation in Brief
Reversible control of CAR expression; plus an inflammation-reducing mAb, two intranasal COVID-19 treatments and more
...named InvisiMask.Intranasal lentiviral vaccine protects against SARS-CoV-2 infectionAlso in a bioRxiv preprint, researchers from the Institut Pasteur...
...spike protein Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Theravectys S.A. Novartis Institutes for BioMedical Research Regeneron Pharmaceuticals Inc. Eureka Therapeutics Inc. Institut Pasteur CD19 Interleukin-1...
...spike protein Danielle Golovin Revlimid, lenalidomide (cdc 501, CC-5013) Theravectys S.A. Novartis Institutes for BioMedical Research Regeneron Pharmaceuticals Inc. Eureka Therapeutics Inc. Institut Pasteur CD19 Interleukin-1...